Perturbations in Endocytotic and Apoptotic Pathways Are Associated With Chemotherapy-Induced Nausea
- PMID: 32815385
- PMCID: PMC8822189
- DOI: 10.1177/1099800420951271
Perturbations in Endocytotic and Apoptotic Pathways Are Associated With Chemotherapy-Induced Nausea
Abstract
Background: While vomiting is well controlled with current antiemetic regimens, unrelieved chemotherapy-induced nausea (CIN) is a significant clinical problem. Perturbations in endocytotic and apoptotic pathways in the gut can influence the functioning of the microbiome-gut-brain-axis and the occurrence of gastrointestinal (GI) symptoms. However, limited information is available on the mechanisms that underlie unrelieved CIN.
Objectives: The purpose of this study was to evaluate for perturbed biological pathways associated with endocytosis and apoptosis in oncology patients who did (n = 353) and did not (n = 275) report CIN prior to their second or third cycle of chemotherapy (CTX).
Methods: Oncology patients (n = 735) completed study questionnaires in the week prior to their second or third cycle of CTX. CIN occurrence was evaluated using the Memorial Symptom Assessment Scale. Pathway impact analyses (PIA) were performed in 2 independent samples using RNA-sequencing (sample 1, n = 334) and microarray (sample 2, n = 294) methodologies. Fisher's combined probability method was used to identify signaling pathways related to endocytotic and apoptotic mechanisms that were significantly perturbed between the 2 nausea groups across both samples.
Results: CIN was reported by 63.6% of the patients in sample 1 and 48.9% of the patients in sample 2. Across the 2 samples, PIA identified 4 perturbed pathways that are involved in endocytosis (i.e., endocytosis, regulation of actin cytoskeleton) and apoptosis (i.e., apoptosis, PI3K/Akt signaling).
Conclusions: Our findings suggest that CTX-induced inflammation of the GI mucosa, that results in the initiation of endocytotic and apoptotic processes in the gut, is associated with the occurrence of CIN.
Keywords: apoptosis; chemotherapy; endocytosis; gene expression; nausea.
Conflict of interest statement
Figures

Similar articles
-
Multiple Gastrointestinal Symptoms Are Associated With Chemotherapy-Induced Nausea in Patients With Breast Cancer.Cancer Nurs. 2022 May-Jun 01;45(3):181-189. doi: 10.1097/NCC.0000000000000976. Cancer Nurs. 2022. PMID: 34183520 Free PMC article.
-
Alterations in Patterns of Gene Expression and Perturbed Pathways in the Gut-Brain Axis Are Associated With Chemotherapy-Induced Nausea.J Pain Symptom Manage. 2020 Jun;59(6):1248-1259.e5. doi: 10.1016/j.jpainsymman.2019.12.352. Epub 2020 Jan 8. J Pain Symptom Manage. 2020. PMID: 31923555 Free PMC article.
-
Gastrointestinal symptoms are associated with trajectories of chemotherapy-induced nausea.Support Care Cancer. 2020 May;28(5):2205-2215. doi: 10.1007/s00520-019-05031-5. Epub 2019 Aug 19. Support Care Cancer. 2020. PMID: 31428931 Free PMC article.
-
A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting.Crit Rev Oncol Hematol. 2018 Jan;121:51-61. doi: 10.1016/j.critrevonc.2017.11.012. Epub 2017 Nov 20. Crit Rev Oncol Hematol. 2018. PMID: 29279099 Free PMC article. Review.
-
Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists.Support Care Cancer. 2017 May;25(5):1661-1671. doi: 10.1007/s00520-017-3585-z. Epub 2017 Jan 20. Support Care Cancer. 2017. PMID: 28108820 Free PMC article. Review.
Cited by
-
Gastrointestinal Symptom Cluster is Associated With Epigenetic Regulation of Lymphotoxin Beta in Oncology Patients Receiving Chemotherapy.Biol Res Nurs. 2023 Jan;25(1):51-64. doi: 10.1177/10998004221115863. Epub 2022 Aug 5. Biol Res Nurs. 2023. PMID: 35929442 Free PMC article.
-
Multiple Gastrointestinal Symptoms Are Associated With Chemotherapy-Induced Nausea in Patients With Breast Cancer.Cancer Nurs. 2022 May-Jun 01;45(3):181-189. doi: 10.1097/NCC.0000000000000976. Cancer Nurs. 2022. PMID: 34183520 Free PMC article.
-
Anxiety in oncology outpatients is associated with perturbations in pathways identified in anxiety focused network pharmacology research.Support Care Cancer. 2023 Nov 28;31(12):727. doi: 10.1007/s00520-023-08196-2. Support Care Cancer. 2023. PMID: 38012456 Free PMC article.
-
The Gut Microbial Lipid Metabolite 14(15)-EpETE Inhibits Substance P Release by Targeting GCG/PKA Signaling to Relieve Cisplatin-Induced Nausea and Vomiting in Rats.J Microbiol Biotechnol. 2024 Sep 28;34(9):1769-1777. doi: 10.4014/jmb.2403.03044. Epub 2024 Jul 15. J Microbiol Biotechnol. 2024. PMID: 39187454 Free PMC article.
References
-
- Al-Dasooqi N., Bowen J. M., Gibson R. J., Logan R. M., Stringer A. M., Keefe D. M. (2011). Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the Dark Agouti rat. International Journal of Experimental Pathology, 92(5), 357–365. 10.1111/j.1365-2613.2011.00771.x - DOI - PMC - PubMed
-
- Aoki-Kinoshita K. F., Kanehisa M. (2007). Gene annotation and pathway mapping in KEGG. Methods in Molecular Biology, 396, 71–91. https://doi.org/1-59745-515-6:71 [pii] - PubMed
-
- Bach S. P., Williamson S. E., O’Dwyer S. T., Potten C. S., Watson A. J. (2006). Regional localisation of p53-independent apoptosis determines toxicity to 5-fluorouracil and pyrrolidinedithiocarbamate in the murine gut. British Journal of Cancer, 95(1), 35–41. 10.1038/sj.bjc.6603224 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical